<SEC-DOCUMENT>0000921895-17-000138-index.html : 20170202
<SEC-HEADER>0000921895-17-000138.hdr.sgml : 20170202
<ACCEPTANCE-DATETIME>20170202172503
ACCESSION NUMBER:		0000921895-17-000138
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20170202
DATE AS OF CHANGE:		20170202

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cascadian Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001412067
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				260868560
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-84961
		FILM NUMBER:		17569431

	BUSINESS ADDRESS:	
		STREET 1:		2601 FOURTH AVENUE
		STREET 2:		SUITE 500
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121
		BUSINESS PHONE:		(206) 801-2100

	MAIL ADDRESS:	
		STREET 1:		2601 FOURTH AVENUE
		STREET 2:		SUITE 500
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Oncothyreon Inc.
		DATE OF NAME CHANGE:	20070927

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biomira CORP
		DATE OF NAME CHANGE:	20070911

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOTECHNOLOGY VALUE FUND L P
		CENTRAL INDEX KEY:			0000918923
		STANDARD INDUSTRIAL CLASSIFICATION:	INVESTMENT ADVICE [6282]
		IRS NUMBER:				363924731
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		1 SANSOME ST
		STREET 2:		30TH FL
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		3125066500

	MAIL ADDRESS:	
		STREET 1:		1 SANSOME ST
		STREET 2:		30TH FL
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>sc13da507422021_02022017.htm
<DESCRIPTION>AMENDMENT NO. 5 TO THE SCHEDULE 13D
<TEXT>
Document 1 - file: sc13da507422021_02022017.htm

</DOCUMENT>
</SEC-DOCUMENT>